Joseph Segelman - Net Worth and Insider Trading

Joseph Segelman Net Worth

The estimated net worth of Joseph Segelman is at least $23,978 dollars as of 2024-04-25. Joseph Segelman is the CEO, 10% Owner of Sigyn Therapeutics Inc and owns about 4,170 shares of Sigyn Therapeutics Inc (SIGY) stock worth over $23,978. Details can be seen in Joseph Segelman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph Segelman has not made any transactions after 2017-06-23 and currently still holds the listed stock(s).

Transaction Summary of Joseph Segelman

To

Joseph Segelman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Segelman owns 1 companies in total, including Sigyn Therapeutics Inc (SIGY) .

Click here to see the complete history of Joseph Segelman’s form 4 insider trades.

Insider Ownership Summary of Joseph Segelman

Ticker Comapny Transaction Date Type of Owner
SIGY Sigyn Therapeutics Inc 2017-06-23 director & 10 percent owner & President & CEO

Joseph Segelman Latest Holdings Summary

Joseph Segelman currently owns a total of 1 stock. Joseph Segelman owns 4,170 shares of Sigyn Therapeutics Inc (SIGY) as of June 23, 2017, with a value of $23,978.

Latest Holdings of Joseph Segelman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SIGY Sigyn Therapeutics Inc 2017-06-23 4,170 5.75 23,978

Holding Weightings of Joseph Segelman


Joseph Segelman Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Segelman has made a total of 0 transactions in Sigyn Therapeutics Inc (SIGY) over the past 5 years. The most-recent trade in Sigyn Therapeutics Inc is the acquisition of 1 shares on June 23, 2017, which cost Joseph Segelman around $1,530.

Insider Trading History of Joseph Segelman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Segelman Trading Performance

GuruFocus tracks the stock performance after each of Joseph Segelman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Segelman is 61.88%. GuruFocus also compares Joseph Segelman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Segelman within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph Segelman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph Segelman

Average Return

-18.41%

Average return per transaction

Outperforming Transactions

40%

2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12.48 61.88 55.57 -18.41 -60.25 -59.71
Relative Return to S&P 500(%) -13.43 58.32 46.88 -33.21 -68.71 -68.56

Joseph Segelman Ownership Network

Ownership Network List of Joseph Segelman

No Data

Ownership Network Relation of Joseph Segelman


Joseph Segelman Owned Company Details

What does Sigyn Therapeutics Inc do?

Who are the key executives at Sigyn Therapeutics Inc?

Joseph Segelman is the director & 10 percent owner & President & CEO of Sigyn Therapeutics Inc. Other key executives at Sigyn Therapeutics Inc include 10 percent owner Australian Sapphire Corp , and director & Secretary Chaya Segelman .

Sigyn Therapeutics Inc (SIGY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sigyn Therapeutics Inc (SIGY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sigyn Therapeutics Inc (SIGY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sigyn Therapeutics Inc (SIGY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sigyn Therapeutics Inc Insider Transactions

No Available Data

Joseph Segelman Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Segelman. You might contact Joseph Segelman via mailing address: 9190 W Olympic Blvd, # 263, Beverly Hills Ca 90212.

Discussions on Joseph Segelman

No discussions yet.